YU65494A - Derivati 1-(2-fluorociklopropil)-hinolon i naftiridon-karbonske kiseline - Google Patents

Derivati 1-(2-fluorociklopropil)-hinolon i naftiridon-karbonske kiseline

Info

Publication number
YU65494A
YU65494A YU65494A YU65494A YU65494A YU 65494 A YU65494 A YU 65494A YU 65494 A YU65494 A YU 65494A YU 65494 A YU65494 A YU 65494A YU 65494 A YU65494 A YU 65494A
Authority
YU
Yugoslavia
Prior art keywords
fluorocyclopropyl
derivatives
naftridone
hinolone
carbic
Prior art date
Application number
YU65494A
Other languages
English (en)
Serbo-Croatian (sh)
Inventor
N. Petersen
T. Schenke
S. Bohm
R. Grosser
K.D. Bremm
R. Edermann
K.G. Metzger
Original Assignee
Bayer Ag.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer Ag. filed Critical Bayer Ag.
Publication of YU65494A publication Critical patent/YU65494A/sh

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
    • C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
    • C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
    • C07D215/54—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3
    • C07D215/56—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen attached in position 3 with oxygen atoms in position 4

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Plural Heterocyclic Compounds (AREA)
YU65494A 1993-11-16 1994-11-11 Derivati 1-(2-fluorociklopropil)-hinolon i naftiridon-karbonske kiseline YU65494A (sh)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
DE4339134A DE4339134A1 (de) 1993-11-16 1993-11-16 1-(2-Fluorcyclopropyl)-chinolon- und -naphthyridoncarbonsäure-Derivate

Publications (1)

Publication Number Publication Date
YU65494A true YU65494A (sh) 1997-09-30

Family

ID=6502741

Family Applications (1)

Application Number Title Priority Date Filing Date
YU65494A YU65494A (sh) 1993-11-16 1994-11-11 Derivati 1-(2-fluorociklopropil)-hinolon i naftiridon-karbonske kiseline

Country Status (27)

Country Link
US (1) US5545642A (env)
EP (1) EP0653425A1 (env)
JP (1) JPH07188230A (env)
KR (1) KR950014114A (env)
CN (1) CN1106412A (env)
AU (2) AU681703B2 (env)
BG (1) BG62003B1 (env)
CA (1) CA2135548A1 (env)
CO (1) CO4180605A1 (env)
CZ (1) CZ280594A3 (env)
DE (1) DE4339134A1 (env)
EE (1) EE9400240A (env)
FI (1) FI945360L (env)
HR (1) HRP940833A2 (env)
HU (1) HUT70175A (env)
IL (1) IL111624A0 (env)
LV (1) LV11328B (env)
NO (1) NO302367B1 (env)
NZ (1) NZ264905A (env)
PE (1) PE32395A1 (env)
PL (1) PL305862A1 (env)
RU (1) RU94040885A (env)
SK (1) SK137194A3 (env)
SV (1) SV1994000064A (env)
TW (1) TW273547B (env)
YU (1) YU65494A (env)
ZA (1) ZA949052B (env)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1994008967A1 (fr) * 1992-10-09 1994-04-28 Chugai Seiyaku Kabushiki Kaisha Derive de fluoroquinoleine
DE69637442T2 (de) * 1995-12-22 2008-05-21 Nagase Chemtex Corp. Wirkstoff gegen helicobacter pylori
CA2294453A1 (en) 1997-06-23 1998-12-30 Fumihiro Hirayama Prophylactic or therapeutic agent for diseases attributable to infection with helicobacters
DE10108750A1 (de) * 2001-02-23 2002-09-05 Bayer Ag Verbessertes Verfahren zur Herstellung von Fluorchinoloncarbonsäuren
WO2004108680A1 (ja) * 2003-06-06 2004-12-16 Daiichi Pharmaceutical Co., Ltd. 光学活性なキノロンカルボン酸誘導体の製造中間体およびその製造法

Family Cites Families (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5274167A (en) * 1989-01-26 1993-12-28 Bayer Aktiengesellschaft Polymeriable optically active (meth) acrylic acid derivatives
DE3910663A1 (de) * 1989-04-03 1990-10-04 Bayer Ag 5-alkylchinoloncarbonsaeuren
KR910009330B1 (ko) * 1989-10-23 1991-11-11 재단법인 한국화학연구소 항균작용을 갖는 퀴놀린계 화합물과 그의 제조방법
KR910009333B1 (ko) * 1989-10-23 1991-11-11 재단법인 한국화학연구소 항균작용을 갖는 퀴놀린계 화합물과 그의 제조방법
KR910009331B1 (ko) * 1989-10-23 1991-11-11 재단법인 한국화학연구소 디아자비시클로아민 화합물과 그의 제조방법
US5696132A (en) * 1991-05-28 1997-12-09 Daiichi Pharmaceutical Co., Ltd. Pyridonecarboxylic acid derivatives
DE4121214A1 (de) * 1991-06-27 1993-01-14 Bayer Ag 7-azaisoindolinyl-chinolon- und -naphthyridoncarbonsaeure-derivate
EP0550016A1 (en) * 1991-12-31 1993-07-07 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and processes for preparing same
WO1994025464A1 (en) * 1993-04-24 1994-11-10 Korea Research Institute Of Chemical Technology Novel quinolone carboxylic acid derivatives and process for preparing the same

Also Published As

Publication number Publication date
FI945360A0 (fi) 1994-11-14
CZ280594A3 (en) 1995-08-16
IL111624A0 (en) 1995-01-24
CN1106412A (zh) 1995-08-09
PL305862A1 (en) 1995-05-29
AU2559997A (en) 1997-09-04
LV11328B (en) 1996-12-20
EE9400240A (et) 1996-02-15
NO944365D0 (no) 1994-11-15
CO4180605A1 (es) 1995-06-07
FI945360A7 (fi) 1995-05-17
HUT70175A (en) 1995-09-28
KR950014114A (ko) 1995-06-15
SV1994000064A (es) 1995-05-25
US5545642A (en) 1996-08-13
BG99179A (en) 1995-07-28
TW273547B (env) 1996-04-01
LV11328A (lv) 1996-06-20
NZ264905A (en) 1995-11-27
PE32395A1 (es) 1995-12-15
AU7773094A (en) 1995-05-25
EP0653425A1 (de) 1995-05-17
SK137194A3 (en) 1995-06-07
HU9403288D0 (en) 1995-01-30
NO944365L (no) 1995-05-18
AU681703B2 (en) 1997-09-04
BG62003B1 (bg) 1998-12-30
ZA949052B (en) 1995-07-19
JPH07188230A (ja) 1995-07-25
FI945360L (fi) 1995-05-17
CA2135548A1 (en) 1995-05-17
NO302367B1 (no) 1998-02-23
RU94040885A (ru) 1996-11-20
HRP940833A2 (en) 1996-12-31
DE4339134A1 (de) 1995-05-18

Similar Documents

Publication Publication Date Title
YU29892A (sh) Postupak za stereoselektivno dobijanje supstituisanih piperidina
YU53298A (en) Aryl pyrimidine derivatives
EA199900559A1 (ru) Замещенные, азотсодержащие гетероциклы в качестве ингибиторов протеинкиназы p38
MY115638A (en) N-substituted heterocyclic derivatives, their preparation and pharmaceutical compositions containing them
YU61192A (sh) Imidazo(2,1-b)(3)benzazepinski derivati i preparati
EA200001176A1 (ru) Гетероциклические ингибиторы p38
UA27100A1 (uk) Заміщеhі піроли, що мають активhість іhгібіторів протеіhкіhази с, а також їх фармацевтичhо прийhятhі кислотhо-адитивhі солі і фармацевтичhа композиція
BG49940A3 (bg) Метод за получаване на производни на 4-/4-фенил-1-пиперазинил/- феноли
HUT34746A (en) Process for the production of 2-pyrimidinil-1-piperazine-derivatives and of medical preparations containing them as agent
YU69991A (sh) Derivati piridina
SE8602723D0 (sv) Thiazoles, their production and pharmaceutical compositions containing them
GEP20012580B (en) Substituted 4-Hydroxy-Phenylalcanoic Acid Derivatives With Agonist Activity to PPAR-Gamma, Methods for Their Production, Pharmaceutical Conposition and Methods for Treatment
FR2559152B1 (fr) Nouveaux derives de la furo-(3,4-c)-pyridine substitues en position 6, ainsi que leur procede de preparation
IT8420396A0 (it) Derivati di furo-(3,4-c)-piridina, loro preparazione e composizioni terapeutiche che li comprendono.
GR3019782T3 (en) Substituted tetrahydropyridines and hydroxypiperidines as central nervous system agents
IL62198A (en) 3,4,5-trihydroxypiperidine compounds,their production and pharmaceutical compositions containing them
PT78854B (fr) Procede de preparation de derives 7-(pyrrol-1-yl)des acides 1-ethyl-1,4-dihydro-4-oxoquinoleine-3-carboxiliques et 1-ethyl-1,4-dihydro-4-oxo-(1,8-naphtyridine)-3-carboxiliques substitues et de compositions pharmaceutiques les contenant
FR2756826B1 (fr) Nouveaux derives tetrahydropyridiniques substitues, leur procede de preparation et les compositions pharmaceutiques qui les contiennent
ATE147388T1 (de) Aminomethyl-substituierte 2,3-dihydropyrano(2,3- b)pyridine, verfahren zu ihrer herstellung und ihre verwendung in arzneimitteln
DE3371076D1 (en) Substituted tert. butanol derivatives, method for their preparation and antimycotic agents containing them
IT1164387B (it) Derivati n-sostituiti dell'1-(4'-alchilsulfonilfenil)-2-ammino-1,3-propandiolo
YU78695A (sh) Derivati piperazina, lekovi koji sadrže dva jedinjenja, njihova primena i postupci za njihovo pripremanje
YU63595A (sh) Derivati hinolon-i naftiridon-karbonske kiseline
UA27242C2 (uk) Комплекс включення 3-морфоліносидноніміну, або його солей, або його таутомірного ізомеру, що має антиішемічний ефект, спосіб їх отримання, фармацевтична композиція, спосіб її одержання та спосіб лікування ішемічної хвороби серця
BG101407A (bg) Пиролил-тетрахидробензохиноксалиндиони, метод за получаването им и използването им като глутамат- рецепторни антагонисти